Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin

作者: Ying Liu , Lan Wang , Yiqing Zhao , Man He , Xin Zhang

DOI: 10.1016/J.IJPHARM.2014.09.052

关键词:

摘要: Abstract Objective Nanostructured lipid carriers and microemulsions effectively deliver poorly water-soluble drugs. However, few studies have investigated their ability difference in improving drug bioavailability, especially the factors contributed to difference. Thus, this study was aimed at investigating efficiency bioavailability enhancement based on studying two key processes that occur NLC ME during traverse along intestinal tract: solubilization process permeability process. Methods The nanostructured had same composition except former were prepared with solid lipids latter liquid lipids; both evaluated for particle size zeta potential. Transmission electron microscopy, differential scanning calorimetry, X-ray diffraction performed characterize properties. Furthermore, vitro release, situ absorption, lipolysis studied. of luteolin delivered using rats compared suspensions. Results analysis revealed different release mechanisms microemulsions, although absorption similar. data indicated digestion speed extent higher than carriers, more partitioned aqueous phase. vivo oral those Conclusion improved luteolin’s rats. rapid much solubilized available may contribute better bioavailability.

参考文章(40)
Panayiotis P. Constantinides, Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects Pharmaceutical Research. ,vol. 12, pp. 1561- 1572 ,(1995) , 10.1023/A:1016268311867
Tsutomu Nakayama, Noriko Saka, Naohide Kinae, Motoyoshi Sato, Izumi Amano, Kayoko Shimoi, Ryushi Nozawa, Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation Drug Metabolism and Disposition. ,vol. 29, pp. 1521- 1524 ,(2001)
Ravi Devraj, Hywel D. Williams, Dallas B. Warren, Kazi Mohsin, Christopher J.H. Porter, Colin W. Pouton, In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine. European Journal of Pharmaceutical Sciences. ,vol. 49, pp. 748- 760 ,(2013) , 10.1016/J.EJPS.2013.04.036
Liang, Bozhong Mu, Yingnian Lu, Wu, Li, He, liao Cui, Characterization and evaluation of an oral microemulsion containing the antitumor diterpenoid compound ent-11alpha-hydroxy-15-oxo-kaur-16-en-19-oic-acid. International Journal of Nanomedicine. ,vol. 8, pp. 1879- 1886 ,(2013) , 10.2147/IJN.S42002
R.H Müller, M Radtke, S.A Wissing, Nanostructured lipid matrices for improved microencapsulation of drugs International Journal of Pharmaceutics. ,vol. 242, pp. 121- 128 ,(2002) , 10.1016/S0378-5173(02)00180-1
Carsten Olbrich, Oliver Kayser, Rainer H Müller, Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)--effect of surfactants, storage time and crystallinity. International Journal of Pharmaceutics. ,vol. 237, pp. 119- 128 ,(2002) , 10.1016/S0378-5173(02)00035-2
Peng-Cheng Lv, Huan-Qiu Li, Jia-Yu Xue, Lei Shi, Hai-Liang Zhu, Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents. European Journal of Medicinal Chemistry. ,vol. 44, pp. 908- 914 ,(2009) , 10.1016/J.EJMECH.2008.01.013
Annekathrin Haberland, Siegfried Wartewig, Karsten Mäder, Wolfgang Mehnert, Katja Jores, Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy. Pharmaceutical Research. ,vol. 22, pp. 1887- 1897 ,(2005) , 10.1007/S11095-005-7148-5